ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $1.1B

      Shares

      27.7M

      % of Portfolio

      0.80%

      Average Buy Price

      $38.6

      Avg closing price
      Price range

      37 PRIMECAP Management GSK Plc Trades

      PRIMECAP Management's position in GSK Plc is currently worth $1.1B. That's 0.80% of their equity portfolio (39th largest holding). The investor owns 1.36% of the outstanding GSK Plc stock. The first GSK Plc trade was made in Q1 2013. Since then PRIMECAP Management bought shares twelve more times and sold shares on 24 occasions. The stake costed the investor $1.07B, netting the investor a gain of 2.7% so far.

      Avg closing price
      Price range
      Increased shares by 7.9% (+2.02M shares) Q2 2025
      Avg closing price $38.20
      Price range $33.60 - $42.49
      Increased shares by 1.8% (+446k shares) Q1 2025
      Avg closing price $36.51
      Price range $32.08 - $40.39
      Increased shares by 70.1% (+10.4M shares) Q4 2024
      Avg closing price $35.92
      Price range $33.35 - $40.30
      Increased shares by 2.4% (+342k shares) Q3 2024
      Avg closing price $40.92
      Price range $38.21 - $44.26
      Increased shares by 13.9% (+1.77M shares) Q2 2024
      Avg closing price $42.07
      Price range $38.50 - $45.78
      Increased shares by 5.4% (+649k shares) Q1 2024
      Avg closing price $41.24
      Price range $37.51 - $43.58
      Increased shares by 0.3% (+30.6k shares) Q4 2023
      Avg closing price $35.90
      Price range $34.17 - $37.56
      Increased shares by 2.4% (+287k shares) Q3 2023
      Avg closing price $35.49
      Price range $33.81 - $38.07
      Increased shares by 19.2% (+1.9M shares) Q2 2023
      Avg closing price $35.87
      Price range $33.60 - $38.32
      Increased shares by 162.1% (+6.11M shares) Q1 2023
      Avg closing price $34.99
      Price range $33.50 - $36.43
      Increased shares by 753.7% (+3.32M shares) Q4 2022
      Avg closing price $33.31
      Price range $30.00 - $37.92
      Sold 20.0% shares (-110k shares) Q3 2022
      Avg closing price $36.31
      Price range $28.66 - $43.91
      Sold 1.4% shares (-7.9k shares) Q2 2021
      Avg closing price $38.44
      Price range $35.82 - $40.66
      Sold 0.6% shares (-3.2k shares) Q4 2019
      Avg closing price $44.50
      Price range $41.19 - $47.32
      Sold 0.4% shares (-2.1k shares) Q3 2019
      Avg closing price $41.15
      Price range $39.68 - $42.68
      Sold 2.1% shares (-12.3k shares) Q2 2019
      Avg closing price $40.14
      Price range $38.64 - $41.88
      Sold 31.6% shares (-267k shares) Q4 2018
      Avg closing price $39.40
      Price range $37.07 - $41.87
      Sold 19.5% shares (-204k shares) Q3 2018
      Avg closing price $40.64
      Price range $38.99 - $41.87
      Sold 2.3% shares (-25.1k shares) Q1 2018
      Avg closing price $37.26
      Price range $35.49 - $39.38
      Sold 0.3% shares (-3k shares) Q4 2017
      Avg closing price $36.96
      Price range $34.66 - $41.10

      News about GSK Plc - ADR and PRIMECAP Management

      Hedge Fund and Insider Trading News: Ken Griffin, Sanjay Shah, David Tepper, Stanley Druckenmiller, Michael Burry, Cevian Capital, Elliott Management, Millennium Management, Eisler Capital, Allogene Therapeutics Inc (ALLO), Carvana Co. (CVNA) and More

      Hedge Fund and Insider Trading News: Ken Griffin, Sanjay Shah, David Tepper, Stanley Druckenmiller, Michael Burry, Cevian Capital, Elliott Management, Millennium Management, Eisler Capital, Allogene Therapeutics Inc (ALLO), Carvana Co. (CVNA) and More

      Billionaire Ken Griffin Goes Heavy On This Tech Stock, Increases Stake By 200% In Two Quarters (IBTimes) Big Asset Managers Including Morgan Stanley, Citadel...

      Insider Monkey Insider Monkey, over 1 year ago
      GSK plc (NYSE:GSK) Shares Acquired by Alhambra Investment Partners LLC

      GSK plc (NYSE:GSK) Shares Acquired by Alhambra Investment Partners LLC

      ¡­ the SEC. The institutional investor owned 15,255 shares ¡­ reporting period. Other institutional investors have also recently made ¡­ quarter. Indiana Trust ...

      EIN News Investing EIN News Investing, over 1 year ago
      ANGLE Announces Senior Management Appointments

      ANGLE Announces Senior Management Appointments

      Brett Swansiger joins as Chief Commercial Officer Karen Miller PhD joins as Chief Scientific Officer GUILDFORD, SURREY / ACCESSWIRE / June 5, 2023 / ANGLE pl...

      Accesswire Accesswire, over 2 years ago
      GSK plc (GSK) Management Presents at dbAcess Global Consumer Conference (Transcript)

      GSK plc (GSK) Management Presents at dbAcess Global Consumer Conference (Transcript)

      Start Time: 09:45 End Time: 10:18 GSK plc (NYSE:NYSE:GSK) dbAcess Global Consumer Conference June 14, 2022, 09:45 AM ET Company Participants Tobias Hestler -...

      Seeking Alpha Seeking Alpha, about 3 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×